Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M100,633Revenue $M9,703Net Margin (%)30.3Z-Score21.8
Enterprise Value $M99,378EPS $12.4Operating Margin %40.8F-Score9
P/E(ttm))34.6Cash Flow Per Share $7.4Pre-tax Margin (%)40.7Higher ROA y-yY
Price/Book9.310-y EBITDA Growth Rate %26.5Quick Ratio1.7Cash flow > EarningsY
Price/Sales10.45-y EBITDA Growth Rate %25.5Current Ratio2.1Lower Leverage y-yY
Price/Cash Flow20.5y-y EBITDA Growth Rate %54.7ROA % (ttm)22.6Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)30.2Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M235ROI % (ttm)19.7Gross Margin Increase y-yY

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIIBJoel Greenblatt 2014-12-31 Reduce-0.08%$299.1 - $360.67
($323.24)
$ 428.9325%Reduce -84.03%5,012
BIIBRay Dalio 2014-12-31 Add0.04%$299.1 - $360.67
($323.29)
$ 428.9325%Add 820.17%15,146
BIIBKen Heebner 2014-12-31 Sold Out -0.75%$299.1 - $360.67
($323.29)
$ 428.9325%Sold Out0
BIIBVanguard Health Care Fund 2014-12-31 Sold Out -0.2%$299.1 - $360.67
($323.29)
$ 428.9325%Sold Out0
BIIBKen Heebner 2014-09-30 Buy 0.75%$299.29 - $346.3
($329.79)
$ 428.9323%New holding80,000
BIIBVanguard Health Care Fund 2014-09-30 Reduce-0.27%$299.29 - $346.3
($329.79)
$ 428.9323%Reduce -58.26%233,600
BIIBJoel Greenblatt 2014-09-30 Buy 0.1%$299.29 - $346.3
($329.79)
$ 428.9323%New holding31,391
BIIBKen Fisher 2014-06-30 Add0.05%$274 - $320.13
($300.74)
$ 428.9330%Add 386.61%88,885
BIIBKen Heebner 2014-06-30 Sold Out -0.95%$274 - $320.13
($300.74)
$ 428.9330%Sold Out0
BIIBAndreas Halvorsen 2014-06-30 Sold Out -0.5%$274 - $320.13
($300.74)
$ 428.9330%Sold Out0
BIIBJoel Greenblatt 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 428.9330%Sold Out0
BIIBGeorge Soros 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 428.9330%Sold Out0
BIIBJohn Burbank 2014-06-30 Sold Out -0.01%$274 - $320.13
($300.74)
$ 428.9330%Sold Out0
BIIBKen Heebner 2014-03-31 Buy 0.95%$273.518 - $351.94
($316.4)
$ 428.9326%New holding116,000
BIIBAndreas Halvorsen 2014-03-31 Buy 0.5%$273.518 - $351.94
($316.4)
$ 428.9326%New holding388,900
BIIBVanguard Health Care Fund 2014-03-31 Reduce-0.24%$273.518 - $351.94
($315.54)
$ 428.9326%Reduce -32.19%599,400
BIIBJoel Greenblatt 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 428.9326%New holding3,931
BIIBGeorge Soros 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 428.9326%New holding7,500
BIIBKen Fisher 2014-03-31 Add0.01%$273.518 - $351.94
($315.54)
$ 428.9326%Add 796.27%18,266
BIIBRon Baron 2014-03-31 Buy 0.01%$273.518 - $351.94
($316.4)
$ 428.9326%New holding6,089
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIIB is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Cox JohnEVP Pharmaceutical Oper & Tech 2015-03-25Sell12,010$449.06-4.48view
Rowinsky Eric KDirector 2015-03-20Sell11,667$475-9.7view
Rowinsky Eric KDirector 2015-03-19Sell2,333$436.14-1.65view
Rowinsky Eric KDirector 2015-03-17Sell4,667$425.450.82view
DiPietro KennethEVP Human Resources 2015-03-16Sell803$415.463.24view
SCANGOS GEORGE ACEO 2015-03-13Sell537$412.693.94view
PANGIA ROBERT WDirector 2015-03-10Sell3,625$413.43.76view
SHERWIN STEPHEN ADirector 2015-03-10Sell6,000$409.674.7view
Rowinsky Eric KDirector 2015-03-09Sell4,666$417.232.8view
Sandrock AlfredGrp SVP, Chief Medical Officer 2015-03-02Sell3,174$409.494.75view

Press Releases about BIIB :

    Quarterly/Annual Reports about BIIB:

    News about BIIB:

    Articles On GuruFocus.com
    Biogen’s Alzheimer’s Drug Shows Promising Test Results Mar 23 2015 
    Biogen Idec (BIIB) At All-time High Levels, KB Home (KBH) Revenue Growth Trajectory, Ctrip (CTRP) Re Mar 23 2015 
    The Best Upcoming Dividend Stocks Mar 20 2015 
    This Week’s Pharma Highlights Mar 19 2015 
    Primecap Management's Annual Shareholder Letter 2014 Mar 09 2015 
    February Pick Of Biotech Stocks Feb 17 2015 
    Stanley Druckenmiller's Recent Trades Feb 13 2015 
    8 Strong Recommendations for 2015 Feb 13 2015 
    Google Joins Biogen In The Fight Against Multiple Sclerosis Jan 29 2015 
    J.P. Morgan Chimes In With Ratings On BioTech Stocks Jan 06 2015 

    More From Our Partners
    Stock Market News for March 26, 2015 - Market News Mar 26 2015 - ZACKS

    More From Other Websites
    Biotech Battering Renews Bubble Debate Over Sector's Pricey Stocks Mar 26 2015
    Biogen Shares Set for Another Pullback Mar 26 2015
    What You Need To Know About This Boom: Our Q&A With A Biotech Expert Mar 26 2015
    Biotech Stock Selloff: Is It Justified? Mar 26 2015
    Healthcare Hedge Fund Orbimed’s Top Picks and New Move Mar 26 2015
    "It's a boom, not a bubble" -- except in biotech, Lindzon says Mar 26 2015
    The Biotech Selloff: It's Déjà Vu All Over Again Mar 26 2015
    The Zacks Analyst Blog Highlights: Biogen, Prothena, Vertex, Gilead and Amgen - Press Releases Mar 26 2015
    One analyst is convinced the biotech stock plunge is 'misguided' Mar 26 2015
    7 Companies That Seriously Should Split Their Stocks Mar 26 2015
    Can Biogen Change How We View Alzheimer's Disease? Mar 25 2015
    Dismal Data Drops Dow 300 Points, Nasdaq Crumbles as Biotech Tumbles Mar 25 2015
    Stock Market Sell-Off: Biotechs, Chips Hardest Hit Mar 25 2015
    Worries Bubble About Biotech Mar 25 2015
    This year's sell off in biotech stocks is starting to look a lot like last year's sell off in... Mar 25 2015
    Biotechs On Track For Worst Week In A Year Mar 25 2015
    Getting it Right (and Wrong) With Leveraged Biotech ETFs Mar 25 2015
    Biogen data reignites debate over Alzheimer's cause as investors back off (Video) Mar 25 2015
    Losses Build For Stocks; Papa Murphy's Bucks Weakness Mar 25 2015
    4 Top-Ranked Health Care ETFs for a Healthy Portfolio - ETF News And Commentary Mar 25 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK